Tandem’s Basal-IQ Gets FDA Interoperable Designation
APRIL 30, 2020
Tandem’s Basal-IQ technology received the FDA’s interoperable automated glycemic controller designation (iAGC) which allows this tech to be paired with different pumps and CGM systems to create an automated insulin dosing (AID) system. This is the second piece of tech from Tandem to receive such designation. To understand what is so important about these interoperable designations, you need to understand the different types of “i” designations and how they will benefit users.